In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Leukemia

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2403385PMID 15141228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal transducer and activator of transcription proteins in leukemias.

  2003cited by this paper
• Cutaneous T‐cell lymphoma

  2003cited by this paper
• What does Stat3 do?

  2002cited by this paper
• What does Stat 3 do ?

  2002cited by this paper
• Signalling: STATs: transcriptional control and biological impact

  2002cited by this paper
• Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3.

  2002cited by this paper
• The role of STATs in apoptosis.

  2002cited by this paper
• Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma1

  2002cited by this paper
• Negative regulation of cytokine signaling

  2001cited by this paper
• Negative Regulators of Cytokine Signaling

  2001cited by this paper
• Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

  2001influential reference
• STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.

  2001cited by this paper
• Interferon-Alpha Induces Transient Suppressors of Cytokine Signalling Expression in Human T Cells

  2001cited by this paper
• Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development

  2000cited by this paper
• Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

  2000cited by this paper
• STAT family of transcription factors in cytokine-mediated biological responses.

  2000cited by this paper
• Keratinocyte‐specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis

  1999cited by this paper
• Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3.

  1999cited by this paper
• Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3.

  1999cited by this paper
• Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

  1999cited by this paper
• Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells

  1999cited by this paper
• The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.

  1999cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.

  1998cited by this paper
• Cutaneous T-cell lymphomas.

  1998cited by this paper
• STAT3 activation accompanies keratinocyte differentiation.

  1998cited by this paper
• Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.

  1997cited by this paper
• Mycosis fungoides and Sezary syndrome.

  1996cited by this paper
• Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.

  1996cited by this paper
• Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.

  1996cited by this paper
• A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells.

  1996cited by this paper
• STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.

  1996cited by this paper
• Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides

  1992cited by this paper
• Cutaneous T‐cell lymphoma

  1976cited by this paper

• Rapid Progression of Cutaneous Lymphoma Following mRNA COVID-19 Vaccination: A Case Report and Pathogenetic Insights

  2025cites this paper
• Angiogenesis and lymphangiogenesis in primary cutaneous lymphomas: a narrative review

  2025cites this paper
• The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression

  2025cites this paper
• Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?

  2025cites this paper
• Phase 1 trial of durvalumab (anti–PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma

  2025cites this paper
• The inhibitory efficacy of Ginsenoside Rg3 on proliferation and migration of colonic carcinoma cells through the JAK3/STAT5 signaling pathway

  2024cites this paper
• Mycosis fungoides: Review and updates

  2023cites this paper
• Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides

  2023cites this paper
• Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas.

  2023cites this paper
• STAT3 Role in T-Cell Memory Formation

  2022cites this paper
• PLC g 1/PKC q Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression

  2022cites this paper
• The cross-talk between miRNAs and JAK/STAT pathway in cutaneous T cell lymphoma: Emphasis on therapeutic opportunities.

  2022cites this paper
• Immunohistochemical Expression Patterns of CD45RO, p105/p50, JAK3, TOX, and IL-17 in Early-Stage Mycosis Fungoides

  2022cites this paper
• Optimization of the molecular genetics for the diagnosis of early mycosis fungoides

  2021cites this paper
• Epigenetic regulation of apoptosis in cutaneous T-cell lymphoma (CTCL): implications for therapy with methotrexate, JAK inhibitors and resveratrol.

  2021cites this paper
• Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy

  2021cites this paper
• Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma

  2021cites this paper
• Transcriptomic Changes During Stage Progression of Mycosis Fungoides

  2021cites this paper
• Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials

  2021cites this paper
• Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas

  2021cites this paper
• Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways.

  2021cites this paper
• Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus

  2021cites this paper
• Malignant T Cell Activation by a Bacillus Species Isolated from Cutaneous T-Cell Lymphoma Lesions

  2021cites this paper
• PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development And Progression.

  2021cites this paper
• The Immunopathogenesis and Immunotherapy of Cutaneous T Cell Lymphoma: Part I, Pathways and Targets for Immune Restoration and Tumor Eradication.

  2020cites this paper
• Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients

  2020cites this paper
• Peripheral T cell lymphomas: from the bench to the clinic

  2020cites this paper
• The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility

  2020cites this paper
• Update on Biology of Cutaneous T-Cell Lymphoma

  2020cites this paper
• Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.

  2020cites this paper
• Mapping signal transducer and activator of transcription (STAT) activity in different stages of mycosis fungoides and Sezary syndrome.

  2020cites this paper
• Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma

  2020cites this paper
• Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma

  2020cites this paper
• Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma.

  2019cites this paper
• JAK/STAT Signaling Pathway and Inhibitors in Inflammatory and Neoplasmatic Skin Diseases

  2019cites this paper
• STAT3 Dysregulation in Mature T and NK Cell Lymphomas

  2019cites this paper
• Advanced‐stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor‐κB and nuclear factor of activated T cells pathways

  2019cites this paper
• Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.

  2019cites this paper
• Prognostic Significance of Serum Copper in Patients With Cutaneous T‐cell Lymphoma

  2019cites this paper
• MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy.

  2019cites this paper
• Pathogenesis of Peripheral T Cell Lymphoma.

  2018cites this paper
• Expression of FK506‐binding protein 51 (FKBP51) in Mycosis fungoides

  2018cites this paper
• Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides

  2018cites this paper
• Screening of ferrocenyl–phosphines identifies a gold-coordinated derivative as a novel anticancer agent for hematological malignancies

  2018cites this paper
• Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome.

  2018cites this paper
• Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma

  2018cites this paper
• Amendment history : Corrigendum ( March 2007 ) Immunopathogenesis and therapy of cutaneous T cell lymphoma

  2018cites this paper
• The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides

  2018cites this paper
• Modern concepts of the mycosis fungoides pathogenesis

  2018cites this paper
• Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

  2017cites this paper
• Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.

  2017influential citation
• Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions

  2017cites this paper
• Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma

  2016cites this paper
• Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover

  2016cites this paper
• STAT5 induces miR-21 expression in cutaneous T cell lymphoma

  2016cites this paper
• STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides

  2016cites this paper
• Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets

  2016cites this paper
• T-cell lymphomas, a challenging disease: types, treatments, and future

  2016cites this paper
• Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.

  2016cites this paper
• Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management

  2016cites this paper
• The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma.

  2016cites this paper
• Non-malignant T cells stimulate growth of T-cell lympho ma cells in the presence of bacterial toxins Short title: Malignant and non-malignant T c ells cross-talk

  2016cites this paper
• The rs9909659G/A polymorphisms of the STAT3 gene provide prognostic information in acute myeloid leukemia

  2016cites this paper
• Tumor microenvironment in mycosis fungoides and Sézary syndrome

  2016cites this paper
• Sézary Syndrome: Clinical and Biological Aspects

  2016cites this paper
• Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma

  2015cites this paper
• Peripheral T‐cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications

  2015influential citation
• Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides

  2015cites this paper
• Immunological and molecular genetic mechanisms of the development of mycosis fungoides

  2015influential citation
• CME Information: Cutaneous T-cell lymphoma: 2016 Update on diagnosis, risk-stratification, and management

  2015cites this paper
• Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

  2015cites this paper
• Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sézary Syndrome

  2015cites this paper
• Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression

  2015cites this paper
• Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma

  2015cites this paper
• Which factors predict incident pressure ulcers in hospitalized patients? A prospective cohort study

  2014cites this paper
• CME Information: Cutaneous T-cell lymphoma: 2014 Update on diagnosis, risk-stratification, and management

  2014cites this paper
• PLCG1 mutations in cutaneous T-cell lymphomas.

  2014cites this paper
• MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.

  2014cites this paper
• Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines

  2014influential citation
• Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.

  2014cites this paper
• CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

  2014cites this paper
• Molecular Diagnostics of Lymphoid Neoplasms

  2014cites this paper
• Möglichkeiten und Grenzen der klonspezifischen, quantitativen Real-Time-PCR bei Patienten mit Sézary Syndrom

  2014cites this paper
• A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert‐Bazin type) mycosis fungoides

  2014cites this paper
• Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

  2014cites this paper
• STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.

  2014cites this paper
• dysregulation Staphylococcal enterotoxins stimulate lymphoma-associated immune

  2014cites this paper
• Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.

  2014cites this paper
• Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management

  2014cites this paper
• Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.

  2013cites this paper
• Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma

  2013cites this paper
• STAT Activation in Malignancies: Roles in Tumor Progression and in the Generation of Antineoplastic Effects of IFNs

  2013cites this paper
• Acute myeloid leukemia: 2013 update on risk‐stratification and management

  2013cites this paper
• Lessons learned from gene expression profiling of cutaneous T‐cell lymphoma

  2013cites this paper
• STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma

  2013influential citation
• for refractory cutaneous T-cell lymphoma (CTCL) Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA)

  2013cites this paper
• A Virtual Culture of CD4+ T Lymphocytes

  2013cites this paper
• Bacterial Toxins Fuel Disease Progression in Cutaneous

  2013cites this paper
• Vascular endothelial growth factor receptor-3 expression in mycosis fungoides

  2013cites this paper
• Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.

  2013cites this paper